These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30679313)

  • 1. The microRNAs miR-449a and miR-424 suppress osteosarcoma by targeting cyclin A2 expression.
    Shekhar R; Priyanka P; Kumar P; Ghosh T; Khan MM; Nagarajan P; Saxena S
    J Biol Chem; 2019 Mar; 294(12):4381-4400. PubMed ID: 30679313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsa_circ_0003732 promotes osteosarcoma cells proliferation via miR-545/CCNA2 axis.
    Li L; Kong XA; Zang M; Dong J; Feng Y; Gui B; Hu Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32537647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-874-mediated inhibition of the major G
    Ghosh T; Varshney A; Kumar P; Kaur M; Kumar V; Shekhar R; Devi R; Priyanka P; Khan MM; Saxena S
    J Biol Chem; 2017 Dec; 292(52):21264-21281. PubMed ID: 29109143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNA-449a is downregulated in osteosarcoma and promotes cell apoptosis by targeting BCL2.
    Chen J; Zhou J; Chen X; Yang B; Wang D; Yang P; He X; Li H
    Tumour Biol; 2015 Sep; 36(10):8221-9. PubMed ID: 26002578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsa_circ_0009910 promotes carcinogenesis by promoting the expression of miR-449a target IL6R in osteosarcoma.
    Deng N; Li L; Gao J; Zhou J; Wang Y; Wang C; Liu Y
    Biochem Biophys Res Commun; 2018 Jan; 495(1):189-196. PubMed ID: 29117539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-449a Sponges Cyclin D1 Expression and Suppresses Phosphorylation of Retinoblastoma Protein against Osteosarcoma.
    Sun Z; Gao M; Li Z; Hao Q; Li L
    Crit Rev Eukaryot Gene Expr; 2021; 31(3):5-19. PubMed ID: 34369711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting EZH2 by microRNA-449a inhibits osteosarcoma cell proliferation, invasion and migration via regulation of PI3K/AKT signaling pathway and epithelial-mesenchymal transition.
    Lu DG; Tang QL; Wei JH; He FY; Lu L; Tang YJ
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1656-1665. PubMed ID: 32141531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
    van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
    J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes.
    Lauvrak SU; Munthe E; Kresse SH; Stratford EW; Namløs HM; Meza-Zepeda LA; Myklebost O
    Br J Cancer; 2013 Oct; 109(8):2228-36. PubMed ID: 24064976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-214 promotes the proliferation and invasion of osteosarcoma cells through direct suppression of LZTS1.
    Xu Z; Wang T
    Biochem Biophys Res Commun; 2014 Jun; 449(2):190-5. PubMed ID: 24802407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma by targeting cyclin-dependent kinase, CDK6.
    Li Y; Liu J; Liu ZZ; Wei WB
    Eur Rev Med Pharmacol Sci; 2016 Dec; 20(24):5117-5125. PubMed ID: 28051259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of microRNA-496 suppresses proliferation, invasion, migration and in vivo tumorigenicity of human osteosarcoma cells by targeting eIF4E.
    Qi NN; Tian S; Li X; Wang FL; Liu B
    Biochimie; 2019 Aug; 163():1-11. PubMed ID: 30998968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-200bc/429 Inhibits Osteosarcoma Cell Proliferation and Invasion by Targeting PMP22.
    Li X; Jiang H; Xiao L; Wang S; Zheng J
    Med Sci Monit; 2017 Feb; 23():1001-1008. PubMed ID: 28234890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of miR-381 on proliferation and prognosis of breast cancer by altering CCNA2 expression.
    Cao MG; Wang Y; Yang ZM; Wang Y; Wang MQ; Zhuo S; Yang Y; Liu CS
    J Obstet Gynaecol; 2024 Dec; 44(1):2360547. PubMed ID: 38904638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
    Zhang C; Long F; Wan J; Hu Y; He H
    Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-221 regulates osteosarcoma cell proliferation, apoptosis, migration, and invasion by targeting CDKN1B/p27.
    Hu XH; Zhao ZX; Dai J; Geng DC; Xu YZ
    J Cell Biochem; 2019 Mar; 120(3):4665-4674. PubMed ID: 30582227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated MiR-27-3p promotes the G1-S phase transition by targeting inhibitor of growth family member 5 in osteosarcoma.
    Ye P; Ke X; Zang X; Sun H; Dong Z; Lin J; Wang L; Liu W; Miao G; Tan Y; Tong W; Xiao H; Gao L
    Biomed Pharmacother; 2018 May; 101():219-227. PubMed ID: 29494959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-187 Inhibits Growth and Metastasis of Osteosarcoma by Downregulating S100A4.
    Xiao Y; Zhao Q; Du B; Chen HY; Zhou DZ
    Cancer Invest; 2018 Jan; 36(1):1-9. PubMed ID: 29303365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑9 depletion suppresses the proliferation of osteosarcoma cells by targeting p16.
    Gao S; Wang J; Tian S; Luo J
    Int J Oncol; 2019 Jun; 54(6):1921-1932. PubMed ID: 31081054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
    Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
    BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.